SCHEMBL27770354

SCHEMBL27770354

COc1cccc(C2=NNC(C=O)N2C2CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
NISCH Q9Y2I1 1/20 0.38
ALDH1A1 P00352 3/20 0.38
NEK2 P51955 1/20 0.37
DYRK1A Q13627 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
NOTUM Q6P988 1/20 0.36
PLK1 P53350 1/20 0.36
NPC1 O15118 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SLC9A1 P19634 1/20 0.36
GNRHR P30968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27770358 0.73 PDE4A (0.32) NPSR1MEN1KMT2A
SCHEMBL27770364 0.71 RXFP1 (0.39) NISCHNOTUMNPC1RAB9ASMN1; SMN2
SCHEMBL27749306 0.69 PTPN11 (0.37) GAAALDH1A1NOTUMNPC1HPGD
SCHEMBL28058456 0.65 ALDH1A1 (0.33) ALDH1A1
SCHEMBL28058563 0.65 MAOA (0.32) NISCHALDH1A1NPC1RAB9ASMN1; SMN2
Ammonia Solution, Strong SCHEMBL27960505 0.64 CYP3A4 (0.70) GAANISCHALDH1A1DYRK1ACLK4
SCHEMBL28058452 0.63 ALDH1A1 (0.31) ALDH1A1
SCHEMBL28058455 0.62
SCHEMBL28058503 0.62
SCHEMBL29489425 0.62 CYP3A4 (0.73) GAANISCHALDH1A1DYRK1ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101495458-B Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors BAYER IP GMBH 2014-01-29 CN disclosed
CN-101495458-A Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors BAYER HEALTHCARE AG (DE) 2009-07-29 CN disclosed